We applaud BioMarin Pharmaceutical Inc. for the official start of the
Enzyme Replacement Therapy (ERT) trial in Germany. Here is the link for more details about the study: BioMarin doses first patient in CLN-2 study
Contact Janet Nuttall at Jnuttall@bmrn.com for enrollment information.
